| |
|
January 29, 2008, Columbia, MD - Washington Biotechnology, Inc. a full-service CRO for in vivo studies, announces an expanded and comprehensive menu of in vivo tests for anti-inflammatory agents. “We continue to expand our services especially relevant to drug or vaccine development for immuno-inflammatory disorders such as arthritis, asthma and diabetes", commented CEO, Sean O’Neill, Ph.D. The Company’s collagen-induced arthritis (CIA) model in mice provides especially useful efficacy information and can include valuable comparison with drugs marketed for treatment of human arthritic conditions. Additional analysis is available through histology and cytokine analysis.
In 2008, the Company enters its 20th year of in vivo testing of compounds or vaccines for conditions including inflammation, cancer (xenograft models), bacterial and viral infections. Experienced personnel provide quality dosing administrations by all types of injections, oral or topical routes as well as sampling for plasma, tissues or organs. Project Management and rapid scheduling of projects is standard for all services.
Newly Available Xenograft Models
Now available: human cell lines for xenograft studies for efficacy treatment testing of breast, colon, lymph nodes, peripheral blood, lung, skin, pancreas, prostate, ovarian and thyroid cancer.
MTD Determination in SW mice - FREE with any xenograft order.
All dosing procedures - Rapid scheduling - Economical studies - Project management
Orthotopic and Custom Xenograft Models
WBI now offers orthotopic xenograft models. In addition to our standard xenograft models, WBI can rapidly develop any xenograft model using your preferred cell line. At no obligation, we will provide pricing and protocol for your specific requirements.
Glioma Brain Cancer Model
WBI offers a subcutaneous xenograft model for athymic nude mice implanted with C6 glioma cells.
The efficacy of test compounds to inhibit tumor growth is measured over a 30-day period. Results are reported weekly. This is another rapid, reliable and economical WBI model for measurement of anti-proliferative efficacy.
Rapid-turnaround PK and TOX Services
Standard mouse and rat PK studies completed within 2 weeks of your order! Also PK for guinea pig, hamster or rabbit - full service, highest quality, fastest service!
TOX studies - acute, chronic - fast start-up, within 2 weeks of your order.
Quality Assurance: Complete Custom Protocol and Quotation for your Study within days of your inquiry.
Project Management, Project Status Reports (e-mail) - all standard on every project.
Breeding, Selections and Genotyping
Please inquire about our breeding programs, selections and genotyping which can be combined with treatment protocols.
Washington Biotechnology regularly exhibits at major international scientific meetings in addition to numerous vendor shows at institutions and companies in North America throughout the year. Our 2008 scheduled shows are highlighted below.
|
|
FOCUS: FDBO (Fort Detrick Business Development Office)
Washington, DC February 20, 2008 |
|
American Association for Cancer Research (AACR) 2008 Annual Meeting
San Diego, CA April 13-16, 2008 Exhibit Booth 305 |
|
15th International Conference of the Inflammation Research Association
Chantilly, VA September 21-24, 2008 |
|
American Society for Cell Biology |
|
American Society of Human Genetics |
|
Biotechnica, Hannover, Germany |
|
ENDO |
|
Neuroscience |
|
U.S. Vendor Shows - UC San Diego, UCSF, UC Berkeley, UC Santa Cruz, Stanford University, Lawrence Livermore National Laboratory, Rocky Mountain National Laboratory, TSRI, University of Texas Medical Center, University of Chicago, University of Illinois, Duke University Medical Center, RTP, University of Michigan, University of Washington, University of Pennsylvania, University of Nevada, Washington University St. Louis.
Canadian Vendor Shows - University of Alberta, University of Calgary, University of British Columbia, University of Western Ontario, University of Toronto. | |
